Overview
Heart Failure Updates for the Clinician
Satellite Symposium
Registration is closed for this activity.
This live symposium provides an opportunity for cardiology professionals to partake in a comprehensive discussion regarding treatment strategies for patients experiencing heart failure.
This satellite symposium is open to all C3 attendees as an additional educational opportunity.
This program is not affiliated with the main C3 conference.
This educational activity is designed for attendees of C3, interventional cardiologists, cardiologists, technologists and nurses involved in the care and treatment of patients with heart failure.
This live symposium aims to provide clarity around current treatment issues for patients with either preserved or reduced ejection fraction heart failure. Advances in both pharmacologic and device-based interventions will be highlighted and faculty will offer best practices about how to utilize these tools either alone or in combination in specific patient populations in order to reduce rehospitalization rates and improve patient outcomes.
Outline evidence-based guideline recommendations for the medical management of heart failure considerate of patients’ past medication histories and comorbidities
Interpret clinical trial efficacy and safety data of new therapies and devices for heart failure
Formulate individualized heart failure therapeutic strategies in patients with either preserved or reduced ejection fraction
Hilton Bonnet Creek
14100 Bonnet Creek Lane
Orlando , FL 32821 USA
Click here to view location map
Phone: 407-597-3600
Comment: Salons 1-3
14100 Bonnet Creek Lane
Orlando , FL 32821 USA
Click here to view location map
Phone: 407-597-3600
Comment: Salons 1-3
Tuesday, June 27, 2017
Salon 1-3
12:30 - 2:00 PM
Salon 1-3
12:30 - 2:00 PM
Sponsored by the Academy for Continued Healthcare Learning
Supported by an educational grant from Novartis Pharmaceuticals Corporation
Chair:
Peter Libby, MD
Brigham and Women’s Hospital
Harvard Medical School
Cardiovascular Specialists – Mallinckrodt Professor of Medicine
Faculty:
James C. Fang, MD
Professor of Medicine
Chief, Division of Cardiovascular Medicine
Executive Director, Cardiovascular Service Line
University of Utah Health Care
Peter Libby, MD
Brigham and Women’s Hospital
Harvard Medical School
Cardiovascular Specialists – Mallinckrodt Professor of Medicine
Faculty:
James C. Fang, MD
Professor of Medicine
Chief, Division of Cardiovascular Medicine
Executive Director, Cardiovascular Service Line
University of Utah Health Care
Sandeep Nathan, MD, MSc
Associate Professor of Medicine
Medical Director, Cardiac Intensive Care Unit Director, Interventional Cardiology Fellowship Program Co-Director, Cardiac Catheterization Laboratory
The University of Chicago Medicine Heart and Vascular Center
Nancy K. Sweitzer, MD, PhD
Director, University of Arizona Sarver Heart Center
Chief, Division of Cardiology
Professor, Medicine, University of Arizona College of Medicine
James Fang, MD
Nothing to disclose
Discussion of Off-Label, Investigational, or Experimental Drug Use: None
Nothing to disclose
Discussion of Off-Label, Investigational, or Experimental Drug Use: None
Peter Libby, MD
Board Member/Advisory Panel: Amgen, Athera biotechnologies, Corvidia Therapeutics, DalCor Pharmaceuticals, Interleukin Genetics, Kowa Pharmaceuticals, Medimmune, Novartis, Olatec Therapeutics
Sources of Funding for Research: Novartis
Discussion of Off-Label, Investigational, or Experimental Drug Use: None
Sandeep Nathan, MD, MSc
Consulting Agreements: AstraZeneca, Cardiovascular Systems, Inc., Jannsen, Medinol, USA, Medtronic, Merit Medical
Speakers' Bureau/Honorarium Agreements: AstraZeneca, Jannsen
Discussion of Off-Label, Investigational, or Experimental Drug Use: None
Nancy Sweitzer, MD, PhD
Sources of Funding for Research Support: Merck; Novartis
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
Guidelines require that participants in CME/CE activities be made aware of all financial relationships that may be perceived as affecting the presentation of the faculty member. ACHL ensures that all faculty and staff involved in the planning, development, and implementation of ACHL activities disclose relevant financial relationships and that conflicts of interest are resolved before the CME/CE activity occurs. Complete information will be provided to participants prior to the start of the educational activity.
To receive credit, participants are required to complete the enrollment/evaluation form and submit on-site. A certificate will be emailed to participants within 6 weeks of receipt of the form. There is no fee to participate in the activity or for the generation of the certificate.
Inquiries may be directed to ACHL at (877) 444-8435, ext. 228.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
